Esaote North America received U.S. Food and Drug Administration (FDA) clearance to market and sell its Virtual Navigator fusion imaging technology for ultrasound to U.S. customers.

 
Boston Scientific Corp. ICD HRS 35th Annual Scientific Sessions SIMPLE Trial

A Boston Scientific Corp. study demonstrated that outcomes for patients with the company's transvenous implantable cardioverter defibrillators (ICD) who received routine defibrillation testing (DT) at implant were similar to outcomes for those patients who did not receive defibrillation testing. 
Elixir Medical Corp. DESolve 100 CE mark

Elixir Medical Corp. received CE mark approval for its DESolve 100 Novolimus Eluting Bioresorbable Coronary Scaffold System.

May 12, 2014 — Patients using the Boston Scientific Latitude remote patient management system with wireless telemetry demonstrated significantly lower mortality and fewer hospitalizations than patients with Latitude-compatible devices who were not followed on the system, according to results from the PREDICt-RM study (Patient RElated Determinants of ICD Remote Monitoring Utilization and Outcomes). The results were presented at Heart Rhythm 2014, the Heart Rhythm Society's (HRS) 35th annual scientific sessions in San Francisco.

May 12, 2014 — The Center for Magnetic Resonance Research (CMRR) at the University of Minnesota, Minneapolis, is the first U.S. facility to install Siemens Healthcare’s Magnetom Prisma, a 3T magnetic resonance imaging (MRI) scanner capable of exceptionally high spatial and temporal resolution to achieve image quality, particularly in highly demanding situations.

May 12 2014 — M*Modal announced enhancements to its Fluency Flex Mobile dictation application for iOS 6.0+ devices. Moving beyond the capture of clinical notes during patient encounters to more robust clinical documentation, the new application allows physicians to select a patient from their appointment schedule to quickly and accurately record clinical notes, improving ease of use and productivity.

The iCT Elite CT system provides low dose, low energy, and low noise with premium results. It is built on technologies that uphold patient-centric clinical quality, including low-contrast resolution and good image quality with reduced artifacts.
 
The system ices IMR, low-contrast resolution software, to help  simultaneously achieve 60–80 percent lower dose, 43–80 percent improved low-contrast detectability, and 70–83 percent lower noise. 
 
Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now